T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense ...

Dr Matthew McKinney reflects on his first experience of treating DLBCL and highlights the advancements in emerging treatments ...

Alternative markers such as CD229 and CD319 can also be introduced into a panel, meaning that it is advisable to check whether or not a targeted antigen is expressed on the malignant plasma cells ...

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma ...

Will further expand Galapagos’ manufacturing network in the U.S. for improved patient experience.